A subset of dominant mutations in the GTPase domain of OPA1, which is directly involved in IMM fusion, has been associated with dominant optic atrophy plus syndrome, defined by the development of additional symptoms such as deafness, ataxia and myopathy throughout adulthood [183,184]. This evidence concerns the gene OPA1 and cerebellar ataxia.